Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Multiple Sclerosis

Free Subscription 08.09.2025 1 BMC Neurol 1 J Neuroimmunol 2 J Neurol 3 J Neurol Neurosurg Psychiatry 6 Mult Scler 3 Neurology 1 Proc Natl Acad Sci U S A

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

BMC Neurol

1. RAGAB S, Fouda BH, Sarhan AA, Abbas A, et al
   Multiple sclerosis patients' journey delay in diagnosis and treatment: a multicenter study.
   BMC Neurol. 2025;25:377.
   PubMed         Abstract available
   
   

   
   J Neuroimmunol

2. TANG Y, Wang H, Wang X, Yan Z, et al
   Characterizing the relationship between FLAIR hyper-rim lesions and paramagnetic rim lesions in multiple sclerosis.
   J Neuroimmunol. 2025;408:578738.
   PubMed         Abstract available
   
   

   
   J Neurol

3. ELLENBERGER D, Frahm N, Stahmann A, Warnke C, et al
   Age-related differences in switching highly effective disease-modifying therapy in patients with multiple sclerosis.
   J Neurol. 2025;272:609.
   PubMed         Abstract available
   
   
4. ASLAN D, Bourabia S, Kowall B, Straukiene A, et al
   The impact of autoimmune comorbidities on multiple sclerosis progression: insights from a longitudinal single-center study.
   J Neurol. 2025;272:607.
   PubMed         Abstract available
   
   

   
   J Neurol Neurosurg Psychiatry

5. MURARO PA, Kazmi M, De Matteis E, Brittain G, et al
   Real-world effectiveness of autologous haematopoietic stem cell transplantation for multiple sclerosis in the UK.
   J Neurol Neurosurg Psychiatry. 2025 Sep 5:jnnp-2025-336755.
   PubMed         Abstract available
   
   
6. GAVOILLE A, Nourredine M, Rollot F, Casey R, et al
   Target trial emulation to replicate randomised clinical trials using registry data in multiple sclerosis.
   J Neurol Neurosurg Psychiatry. 2025 Sep 4:jnnp-2025-336762.
   PubMed         Abstract available
   
   
7. CALVI A, Vivo Pascual F, Solana E, Lopez-Soley E, et al
   Diffusivity anisotropy signature of the slowly expanding lesions predicts progression independent of relapse activity in multiple sclerosis.
   J Neurol Neurosurg Psychiatry. 2025 Sep 1:jnnp-2025-335884.
   PubMed         Abstract available
   
   

   
   Mult Scler

8. DERSCH R, Wiendl H
   'Anti-B cell CAR-T therapy in multiple sclerosis is simply a more profound immunoablation': Yes.
   Mult Scler. 2025 Aug 29:13524585251364140. doi: 10.1177/13524585251364140.
   PubMed        
   
   
9. MASSEY J, Monif M
   Anti-B-cell CAR-T therapy in multiple sclerosis is simply a more profound immunoablation? Commentary.
   Mult Scler. 2025 Aug 29:13524585251370085. doi: 10.1177/13524585251370085.
   PubMed        
   
   
10. BRUNO A, Greco R
    Anti-B-cell CAR-T therapy in multiple sclerosis is simply a more profound immunoablation? No.
    Mult Scler. 2025 Aug 29:13524585251364144. doi: 10.1177/13524585251364144.
    PubMed        
    
    
11. TOUBASI AA, Graham M, Cutter G, Gheen C, et al
    Comparing the macromolecular-to-free pool size ratio and the magnetization transfer ratio for the assessment of myelin injury in early multiple sclerosis.
    Mult Scler. 2025 Sep 1:13524585251364766. doi: 10.1177/13524585251364766.
    PubMed         Abstract available
    
    
12. LI J, Hutton GJ, Aparasu RR
    Prevalence of multiple sclerosis and disease-modifying therapy use in older adults in the United States, 2011-2021.
    Mult Scler. 2025 Sep 2:13524585251368687. doi: 10.1177/13524585251368687.
    PubMed         Abstract available
    
    
13. LARONI A, Vigo T, Inglese M, Uccelli A, et al
    Immunosenescence in multiple sclerosis: New insights and clinical implications.
    Mult Scler. 2025 Sep 2:13524585251367611. doi: 10.1177/13524585251367611.
    PubMed         Abstract available
    
    

    
    Neurology

14. CORTESE R, Sforazzini F, Gentile G, de Mauro A, et al
    Deep Learning Modeling to Differentiate Multiple Sclerosis From MOG Antibody-Associated Disease.
    Neurology. 2025;105:e214075.
    PubMed         Abstract available
    
    
15. CHARD DT
    Diagnosing Multiple Sclerosis: An Imperfect but Evolving Process.
    Neurology. 2025;105:e214057.
    PubMed        
    
    
16. RENNER B, Verter ED, Absinta M, Daboul L, et al
    Frequency and Diagnostic Implications of Paramagnetic Rim Lesions in People Presenting for Diagnosis to a Multiple Sclerosis Clinic.
    Neurology. 2025;105:e213912.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

17. MYKICKI N, Eble JA, Weighardt H, Gonnelli E, et al
    AhR signaling in skin-resident CD207(+) cells is involved in UV-B-induced amelioration of neuroinflammation.
    Proc Natl Acad Sci U S A. 2025;122:e2424009122.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Multiple Sclerosis is free of charge.